News and reflections from the world of AI

    April 29, 2022

    AI: the truths revealed and the rumors debunked

    Introduction Confused about the evolution of Artificial Intelligence (AI)? What does AI even really mean? Learn more about the facts and fiction of this rapidly emerging technology.
    Written by Aiforia
    April 7, 2022

    Benefits of AI in preclinical studies

    The preclinical phase of drug discovery involves extensive safety evaluations of the potential therapeutic intervention, often using cell and animal models of disease. These studies commonly include going through numerous histopathological samples. This contributes to the drug development process being time-consuming and labor-intensive for pharmaceutical and contract research organizations.
    Written by Aiforia
    November 15, 2021

    Digital pathology in drug development

    Currently, drug development is very time consuming and labor-intensive. Scientists and pathologists go through hundreds of samples identifying variations to assess how a drug affects a certain tissue or animal. Digital pathology and artificial intelligence (AI) are extremely valuable in this process by improving efficiency. For example, toxicologic pathology research generates a huge number of ...
    Written by Aiforia
    October 21, 2021

    Infectious Diseases and AI

    Introduction Infectious diseases come from microorganisms, such as bacteria, viruses, fungi, or parasites. The pathogens are transmitted, directly or indirectly, and can lead to epidemics or even pandemics as seen recently with coronavirus. While some infected individuals remain asymptomatic, many infectious diseases have severe consequences and can be fatal. Infectious diseases are a leading ...
    Written by Aiforia
    July 26, 2021

    AI in toxicologic pathology: an overview

    Toxicologic Pathology Toxicologic pathology, the study of chemicals’ adverse effects on animal models of human diseases, has a significant use in preclinical drug assessment. Toxicologic pathologists are crucial for drug discovery and chemical safety assessments due to their skills in informational interpretation from a broad range of disciplines. This is particularly relevant for the various ...
    Written by Aiforia
    April 22, 2021

    Aiforia and X-ZELL partner to scale up novel AI-powered method for early cancer detection

    Singapore, Helsinki -- Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis, and X-ZELL, a clinical stage med-tech company aiming to make early, affordable cancer detection accessible to everyone, have entered into a strategic partnership to integrate X-ZELL’s novel rare cell detection technology with Aiforia’s deep learning AI software.
    Written by Aiforia
    1 2 3 4 5